215 OPERAM: intervention protocol References 1. The European Commission. Europe needs to prepare for growing older. 2012. 2. Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens EJM, Kromhout D. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10year all-cause mortalitym: the FINE study (Finland, Italy, Netherlands, elderly) J Clin Epidemiol. 2001;54(7):680–686. 3. Anderson G. Chronic care: making the case for ongoing care. Robert Wood Johnson Found. 2010:1–43. 4. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):1–10. 5. Maher R, Hanlon J, Hajjar E. Clinical consequences of Polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):1–11. 6. Ahern F, Sahm LJ, Lynch D, McCarthy S. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University hospital: a crosssectional study. Emerg Med J. 2014;31(1):24–29. 7. Pirmohamed M, James S, Meakin S, Green C. Adverse drug reactions as cause of admission to hospital. BMJ Br Med J. 2004;329(7463):460. 8. Fulton M, Riley AE. Polypharmacy in the elderly - {a} literature review. J Am Acad Nurse Pract. 2005;17(4):123. 9. Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–854. 10. Mcintosh J, Alonso A, Maclure K, Stewart D, Kempen T, Mair A, et al. A case study of polypharmacy management in nine European countries : implications for change management and implementation. PLoS One. 2018;13(4):1–20. 11. Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857–866. 12. McDonald E, Wu PE, Rashidi B, Forster AJ, Huang A, Pilote L, Papillon-Ferland L, Bonnici A, Tamblyn R, Whitty R, Porter S, Battu K, Downar J, Lee TC. The MedSafer study: a controlled trial of an electronic decision support tool for Deprescribing in acute care. J Am Geriatr Soc. 2019;67(9):1843–1850. 13. Patterson S, Cadogan C, Kerse N, Cardwell C, Bradley M, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy for older people interventions to improve the appropriate use of polypharmacy for older people (review). Cochrane Database Syst Rev. 2014;10. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008165. pub3/full. 14. O’Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010;1(1):45–51. 15. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218. 16. O’Connor MN, O’Sullivan D, Gallagher PF, Eustace J, Byrne S, O’Mahony D. Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016;64(8):1558–1566. 3
RkJQdWJsaXNoZXIy MTk4NDMw